Literature DB >> 171862

Cyclic adenosine-3',5-monophosphate concentration and enzyme activities of cerebrospinal fluid in meningitis of children.

E R Heikkinen, S Similä, V V Myllylä, E Hokkanen, H Vapaatalo.   

Abstract

The concentration of cyclic adenosine-3',5'-monophosphate (cAMP) and the activities of some enzymes of 29 children were measured from cerebrospinal fluid (CSF) and plasma at various stages of meningitis. The CSF cAMP values in acute untreated phase of aseptic and purulent meningitis were equal, but significantly higher than those of convalescent children with no pathological clinical or laboratory findings. During the whole course (up to 2 weeks) of antimicrobial treatment of the purulent meningitis CSF cAMP concentration was higher than in the convalescent phase. Of the CSF enzymes studied, the lactic dehydrogenase activity seemed to be the best indicator of changing stages of meningitis. It was clearly elevated in the acute, untreated phase of purulent meningitis then decreasing during the course of treatment. In aseptic meningitis this activity was at the normal level and the activities of creatine kinase and acid phosphatase behaved similarly. The plasma cAMP concentrations in the acute phase of purulent meningitis were in the same range as in the CSF. During the treatment no significant changes were seen. The enzyme activities in the plasma were normal. The CSF cAMP level seems to be a sensitive indicator of metabolic disturbances in meningitis and may serve as a diagnostic aid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171862     DOI: 10.1007/bf00440263

Source DB:  PubMed          Journal:  Z Kinderheilkd        ISSN: 0044-2917


  21 in total

1.  Cerebrospinal fluid concentration and urinary excretion of cyclic adenosine-3', 5'-monophosphate in various diseases of children.

Authors:  V V Myllylä; E R Heikkinen; S Similä; E Hokkanen; H Vapaatalo
Journal:  Z Kinderheilkd       Date:  1975

2.  Effect of probenecid on levels of cyclic AMP in human cerebrospinal fluid.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  J Neurochem       Date:  1972-06       Impact factor: 5.372

3.  Adenyl cyclase and phosphodiesterase activities in brain areas of man, monkey and rat.

Authors:  R H Williams; S A Little; J W Ensinck
Journal:  Am J Med Sci       Date:  1969-09       Impact factor: 2.378

4.  Effects of probenecid and exercise on cerebrospinal-fluid cyclic A.M.P. in affective illness.

Authors:  H Cramer; F K Goodwin; R M Post; W E Bunney
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

5.  Regional and subcellular distribution of adenyl cyclase and 3',5'-cyclic nucleotide phosphodiesterase in brain and pineal gland.

Authors:  B Weiss; E Costa
Journal:  Biochem Pharmacol       Date:  1968-10       Impact factor: 5.858

6.  Leukocyte lactate dehydrogenase in bacterial meningitis.

Authors:  D W Powers; E M Ayoub
Journal:  Pediatrics       Date:  1974-07       Impact factor: 7.124

7.  Enzymatic activities in cerebrospinal fluid in patients with neurological diseases.

Authors:  J Hildebrand; S Levin
Journal:  Acta Neurol Belg       Date:  1973 Jul-Aug       Impact factor: 2.396

8.  Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in neurological disease.

Authors:  G A Davies-Jones
Journal:  J Neurol Sci       Date:  1970-12       Impact factor: 3.181

9.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Authors:  A E Broadus; N I Kaminsky; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine.

Authors:  R W BUTCHER; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

View more
  5 in total

1.  Decreased cerebrospinal fluid cyclic adenosine 3',5'-monophosphate in bacterial meningitis.

Authors:  S Weitzman; L B Palmer; S A Berger
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

2.  Elevated CSF cyclic AMP concentrations in patients with inflammatory diseases of cerebral and extracerebral origin.

Authors:  A A Roscher; A Thetter; U N Wiesmann; F Vassella
Journal:  Eur J Pediatr       Date:  1980-08       Impact factor: 3.183

3.  Cyclic adenosine 3',5' monophosphate in cerebrospinal fluid of multiple sclerosis patients.

Authors:  E Maida; W Kristoferitsch
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Studies on cyclic AMP in different compartments of cerebrospinal fluid.

Authors:  D Tsang; S Lal; T L Sourkes; R M Ford; A Aronoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

5.  [Lysozyme and beta2-microglobulin in cerebrospinal fluids from healthy children and in children with diseases of the central nervous system (author's transl)].

Authors:  D Gekle; J Kult; R Roth
Journal:  Klin Wochenschr       Date:  1977-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.